Johnson & Johnson Commits Over $2 Billion to Build New Manufacturing Plant in North Carolina
On Tuesday, Johnson & Johnson (NYSE: JNJ) said it will invest more than $2 billion to build a new manufacturing […]
NYSE: JNJ
Johnson & Johnson (NYSE: JNJ) Subsidiary Files for Bankruptcy to Advance $10 Billion Talc Settlement
A Johnson & Johnson (NYSE: JNJ) subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant
Johnson & Johnson (NYSE: JNJ) to Face New Trial After Oregon Judge Overturns $260M Talc Verdict
A state judge in Oregon has overturned a jury’s $260 million verdict against Johnson & Johnson (NYSE: JNJ) in a
Johnson & Johnson (NYSE: JNJ) in Talks With Holdouts to Secure $6.48 Billion Talc Settlement
NEW YORK – On Friday, Johnson & Johnson (NYSE: JNJ) said it is negotiating with plaintiffs’ lawyers who have opposed
US FDA Approves Johnson & Johnson’s Combination Therapy for a Type of Lung Cancer
On Tuesday, the U.S. Food and Drug Administration approved Johnson & Johnson’s (NYSE: JNJ) chemotherapy-free combination treatment for a type
US FDA Approves Johnson & Johnson’s Combination Therapy for a Type of Lung Cancer Read More »
Exclusive: Johnson & Johnson (NYSE: JNJ) Near Disclosing Support For Talc Settlement, Sources Say
NEW YORK – Johnson & Johnson (NYSE: JNJ) is preparing to unveil widespread support in the coming days for a
Johnson & Johnson (NYSE: JNJ) Clears Major Hurdle in $6.5 Billion Talc Settlement
NEW YORK – Johnson & Johnson (NYSE: JNJ) has cleared a key threshold of support for its proposed $6.5 billion
Johnson & Johnson (NYSE: JNJ) Clears Major Hurdle in $6.5 Billion Talc Settlement Read More »
Johnson & Johnson (NYSE: JNJ) Stock Jumps on Strong Q2 Earnings and Revenue Figures
Johnson & Johnson (NYSE: JNJ) reported better-than-expected earnings for the second quarter on Thursday and raised its full-year profit outlook.
Johnson & Johnson (NYSE: JNJ) Stock Jumps on Strong Q2 Earnings and Revenue Figures Read More »